TXN and prostate cancer: Moreover, parthenolide increased ROS levels causing the oxidation of thioredoxin (TrX) in a LNCaP, PC3 and Duke University 145 (DU145) prostate cancer cells leading to a TrX-dependent increase on the reduction in KEAP1.